193 related articles for article (PubMed ID: 27165818)
1. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.
Zager RA; Johnson AC; Frostad KB
Kidney Int; 2016 Jul; 90(1):67-76. PubMed ID: 27165818
[TBL] [Abstract][Full Text] [Related]
2. Marked protection against acute renal and hepatic injury after nitrited myoglobin + tin protoporphyrin administration.
Zager RA
Transl Res; 2015 Nov; 166(5):485-501. PubMed ID: 26117289
[TBL] [Abstract][Full Text] [Related]
3. Tin protoporphyrin activates the oxidant-dependent NRF2-cytoprotective pathway and mitigates acute kidney injury.
Johnson ACM; Delrow JJ; Zager RA
Transl Res; 2017 Aug; 186():1-18. PubMed ID: 28586635
[TBL] [Abstract][Full Text] [Related]
4. Acute hepatic ischemic-reperfusion injury induces a renal cortical "stress response," renal "cytoresistance," and an endotoxin hyperresponsive state.
Zager RA; Johnson AC; Frostad KB
Am J Physiol Renal Physiol; 2014 Oct; 307(7):F856-68. PubMed ID: 25080526
[TBL] [Abstract][Full Text] [Related]
5. Iron sucrose ('RBT-3') activates the hepatic and renal HAMP1 gene, evoking renal hepcidin loading and resistance to cisplatin nephrotoxicity.
Zager RA; Johnson ACM; Therapeutics R
Nephrol Dial Transplant; 2021 Feb; 36(3):465-474. PubMed ID: 33547792
[TBL] [Abstract][Full Text] [Related]
6. Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.
Johnson AC; Becker K; Zager RA
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F426-35. PubMed ID: 20504881
[TBL] [Abstract][Full Text] [Related]
7. The NRF2 stimulating agent, tin protoporphyrin, activates protective cytokine pathways in healthy human subjects and in patients with chronic kidney disease.
Zager RA; Johnson ACM
Physiol Rep; 2020 Sep; 8(18):e14566. PubMed ID: 32940965
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and consequences of oxidant-induced renal preconditioning: an Nrf2-dependent, P21-independent, anti-senescence pathway.
Johnson ACM; Zager RA
Nephrol Dial Transplant; 2018 Nov; 33(11):1927-1941. PubMed ID: 29522116
[TBL] [Abstract][Full Text] [Related]
9. 6-Shogaol protects against ischemic acute kidney injury by modulating NF-κB and heme oxygenase-1 pathways.
Han SJ; Kim M; D'Agati VD; Lee HT
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F743-F756. PubMed ID: 31313953
[TBL] [Abstract][Full Text] [Related]
10. Age sensitizes the kidney to heme protein-induced acute kidney injury.
Nath KA; Grande JP; Farrugia G; Croatt AJ; Belcher JD; Hebbel RP; Vercellotti GM; Katusic ZS
Am J Physiol Renal Physiol; 2013 Feb; 304(3):F317-25. PubMed ID: 23195679
[TBL] [Abstract][Full Text] [Related]
11. Ischemic preconditioning protects against liver ischemia/reperfusion injury via heme oxygenase-1-mediated autophagy.
Liu A; Fang H; Wei W; Dirsch O; Dahmen U
Crit Care Med; 2014 Dec; 42(12):e762-71. PubMed ID: 25402296
[TBL] [Abstract][Full Text] [Related]
12. Oxidant- induced preconditioning: A pharmacologic approach for triggering renal 'self defense'.
Zager RA
Physiol Rep; 2022 Oct; 10(20):e15507. PubMed ID: 36305701
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of artemisia asiatica extract against renal ischemia-reperfusion injury in mice.
Jang HJ; Jeong EK; Kim SS; Lee JH; Oh MY; Kang KS; Kwan HC; Song KI; Eom DW; Han DJ
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():377-82. PubMed ID: 25894194
[TBL] [Abstract][Full Text] [Related]
14. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat.
Agarwal A; Balla J; Alam J; Croatt AJ; Nath KA
Kidney Int; 1995 Oct; 48(4):1298-307. PubMed ID: 8569092
[TBL] [Abstract][Full Text] [Related]
15. Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat.
Leung N; Croatt AJ; Haggard JJ; Grande JP; Nath KA
Kidney Int; 2001 Sep; 60(3):1047-57. PubMed ID: 11532099
[TBL] [Abstract][Full Text] [Related]
16. Dual effect of hemin on renal ischemia-reperfusion injury.
Rossi M; Delbauve S; Wespes E; Roumeguère T; Leo O; Flamand V; Le Moine A; Hougardy JM
Biochem Biophys Res Commun; 2018 Sep; 503(4):2820-2825. PubMed ID: 30100067
[TBL] [Abstract][Full Text] [Related]
17. Infusion of IL-10-expressing cells protects against renal ischemia through induction of lipocalin-2.
Jung M; Sola A; Hughes J; Kluth DC; Vinuesa E; Viñas JL; Pérez-Ladaga A; Hotter G
Kidney Int; 2012 May; 81(10):969-982. PubMed ID: 22278021
[TBL] [Abstract][Full Text] [Related]
18. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis.
Scindia Y; Dey P; Thirunagari A; Liping H; Rosin DL; Floris M; Okusa MD; Swaminathan S
J Am Soc Nephrol; 2015 Nov; 26(11):2800-14. PubMed ID: 25788528
[TBL] [Abstract][Full Text] [Related]
20. Parenterial iron sucrose-induced renal preconditioning: differential ferritin heavy and light chain expression in plasma, urine, and internal organs.
Johnson AC; Gooley T; Guillem A; Keyser J; Rasmussen H; Singh B; Zager RA
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1563-F1571. PubMed ID: 31608670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
